Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Krista Dybtved Kjærgaard"'
Autor:
Christian Daugaard Peters, Krista Dybtved Kjærgaard, Bente Jespersen, Kent Lodberg Christensen, Jens Dam Jensen
Publikováno v:
Artery Research, Vol 24 (2018)
Background: Troponin T (TnT) is a highly specific biomarker for myocardial infarction (MI). Haemodialysis (HD) patients often have increased arterial stiffness and elevated TnT. Previous studies have linked elevated TnT with worse outcome, even in th
Externí odkaz:
https://doaj.org/article/1f2e69e86dc946b5b5562eb35dbd37c5
Autor:
Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, Kent Lodberg Christensen, Charlotte Strandhave, Ida Noerager Tietze, Marija Kristina Novosel, Bo Martin Bibby, Bente Jespersen
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0126882 (2015)
Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan.Randomized, double-blind, placebo-controlled, one-year interve
Externí odkaz:
https://doaj.org/article/b8927e0d078b462cbef7ff907c9b9a9d
Autor:
Hanne Sandstrøm, Jens Brøndum Frøkjær, Jens Dam Jensen, Krista Dybtved Kjaergaard, Marie Frimodt-Møller, Inge Petersen, Charlotte Strandhave, Niels Erik Frandsen, Carsten Toftager Larsen, Jonna Skov Madsen, Anne Schmedes, Ditte Hansen, Karin Levy-Schousboe, Christian Daugaard Peters, Peter Marckmann, Hanne Elming, Niklas Rye Jørgensen, Claus Lohman Brasen
Publikováno v:
Clinical Kidney Journal
Levy-Schousboe, K, Frimodt-Møller, M, Hansen, D, Peters, C D, Kjærgaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrøm, H, Brasen, C L, Schmedes, A, Madsen, J S, Jørgensen, N R, Frøkjær, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis : results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Levy-Schousboe, K, Frimodt-Moller, M, Hansen, D, Peters, C D, Kjaergaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrom, H, Brasen, C L, Schmedes, A, Madsen, J S, Jorgensen, N R, Frokjaer, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis : results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Levy-Schousboe, K, Frimodt-Møller, M, Hansen, D, Peters, C D, Kjærgaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrøm, H, Brasen, C L, Schmedes, A, Madsen, J S, Jørgensen, N R, Frøkjær, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Levy-Schousboe, K, Frimodt-Møller, M, Hansen, D, Peters, C D, Kjærgaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrøm, H, Brasen, C L, Schmedes, A, Madsen, J S, Jørgensen, N R, Frøkjær, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis : results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Levy-Schousboe, K, Frimodt-Moller, M, Hansen, D, Peters, C D, Kjaergaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrom, H, Brasen, C L, Schmedes, A, Madsen, J S, Jorgensen, N R, Frokjaer, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis : results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Levy-Schousboe, K, Frimodt-Møller, M, Hansen, D, Peters, C D, Kjærgaard, K D, Jensen, J D, Strandhave, C, Elming, H, Larsen, C T, Sandstrøm, H, Brasen, C L, Schmedes, A, Madsen, J S, Jørgensen, N R, Frøkjær, J B, Frandsen, N E, Petersen, I & Marckmann, P 2021, ' Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial ', Clinical Kidney Journal, vol. 14, no. 9, pp. 2114-2123 . https://doi.org/10.1093/ckj/sfab017
Arterial calcification is associated with cardiovascular mortality in dialysis patients. Active matrix Gla protein (MGP) is a vitamin K-dependent inhibitor of arterial calcification. Elevated plasma concentrations of inactive MGP, i.e. dephosphorylat
Autor:
Bibby Bm, Krista Dybtved Kjaergaard, Jens Dam Jensen, Jespersen B, Christian Daugaard Peters, Christensen Kl
Background Troponin T (TnT) is a well-known risk factor for negative outcome in hemodialysis (HD) patients, but little is known about variation over time, and the impact of clinical and dialysis specific factors. This study investigated the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db6cdda611572440a6d85c4fed4c30ee
https://doi.org/10.21203/rs.2.21910/v1
https://doi.org/10.21203/rs.2.21910/v1
Autor:
Bente Jespersen, Jens Dam Jensen, Bo Martin Bibby, Christian Daugaard Peters, Kent L. Christensen, Krista Dybtved Kjaergaard
Publikováno v:
BMC Nephrology
Peters, C D, Kjaergaard, K D, Christensen, K L, Bibby, B M, Jespersen, B & Jensen, J D 2020, ' High-sensitivity Troponin T in hemodialysis patients : a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome ', BMC Nephrology, vol. 21, no. 1, 452 . https://doi.org/10.1186/s12882-020-02103-1
BMC Nephrology, Vol 21, Iss 1, Pp 1-15 (2020)
Peters, C D, Kjaergaard, K D, Christensen, K L, Bibby, B M, Jespersen, B & Jensen, J D 2020, ' High-sensitivity Troponin T in hemodialysis patients : a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome ', BMC Nephrology, vol. 21, no. 1, 452 . https://doi.org/10.1186/s12882-020-02103-1
BMC Nephrology, Vol 21, Iss 1, Pp 1-15 (2020)
Background Troponin T (TnT) is a well-known risk factor for negative outcome in hemodialysis (HD) patients, but little is known about variation over time, and the impact of clinical and dialysis specific factors. This study investigated the effect of
Autor:
Bente Jespersen, Christian Daugaard Peters, Jens Dam Jensen, Christina G. Poulsen, Krista Dybtved Kjaergaard
Publikováno v:
Hemodialysis International. 21:409-421
Introduction Health related quality of life (HRQOL) is markedly reduced in hemodialysis patients compared to the general population. We investigated the course of self-reported HRQOL over time and the association with selected factors, focusing on ch
Autor:
Bente Jespersen, Claus H Nielsen, Jens Dam Jensen, Christian Daugaard Peters, Kent L. Christensen, Krista Dybtved Kjaergaard, Bo Martin Bibby
Publikováno v:
Hemodialysis International. 21:47-62
Introduction: Low-grade chronic inflammation is common in hemodialysis (HD) patients. Previous studies suggest an anti-inflammatory effect of angiotensin II receptor blocker (ARB) treatment. The aim of this study was to compare the effect of ARB vs.
Autor:
Bente Jespersen, Jens Dam Jensen, Christian Daugaard Peters, Kent L. Christensen, Krista Dybtved Kjaergaard
Publikováno v:
Artery Research, Vol 24 (2018)
Background: Troponin T (TnT) is a highly specific biomarker for myocardial infarction (MI). Haemodialysis (HD) patients often have increased arterial stiffness and elevated TnT. Previous studies have linked elevated TnT with worse outcome, even in th
Autor:
Bente Jespersen, Jens Dam Jensen, Niels Johansen, Christian Daugaard Peters, Michael Pedersen, Krista Dybtved Kjaergaard
Publikováno v:
Johansen, N, Kjaergaard, K D, Peters, C D, Pedersen, M, Jespersen, B & Jensen, J D 2017, ' Brain swelling during dialysis: A randomized trial comparing low-flux hemodialysis with pre-dilution hemodiafiltration ', Clinical Nephrology, vol. 87, no. 5, pp. 221-230 . https://doi.org/10.5414/CN108931
Osmotic changes in plasma are assumed to cause cerebral swelling in hemodialysis patients. We investigated the acute effect of low-flux hemodialysis (HD) (removal of small molecules) and pre-dilution hemodiafiltration (pre-HDF) (additional removal of
Autor:
Jens Dam Jensen, Ida N Tietze, Charlotte Strandhave, Krista Dybtved Kjaergaard, Kathrine Skaaning Laursen, Christian Daugaard Peters, Bente Jespersen, Marija Kristina Novosel, Jens Kristian Madsen, Bo Martin Bibby, Birgitte Bang Pedersen
Publikováno v:
Kjaergaard, K D, Peters, C D, Jespersen, B, Tietze, I N, Madsen, J K, Pedersen, B B, Novosel, M K, Laursen, K S, Bibby, B M, Strandhave, C & Jensen, J D 2014, ' Angiotensin Blockade and Progressive Loss of Kidney Function in Hemodialysis Patients : A Randomized Controlled Trial ', American journal of kidney diseases : the official journal of the National Kidney Foundation, vol. 64, no. 6, 6, pp. 892-901 . https://doi.org/10.1053/j.ajkd.2014.05.011
Kjaergaard, K D, Peters, C D, Jespersen, B, Tietze, I N, Madsen, J K, Pedersen, B B, Novosel, M K, Laursen, K S, Bibby, B M, Strandhave, C & Jensen, J D 2014, ' Angiotensin Blockade and Progressive Loss of Kidney Function in Hemodialysis Patients : A Randomized Controlled Trial ', American Journal of Kidney Diseases, vol. 64, no. 6, pp. 892-901 . https://doi.org/10.1053/j.ajkd.2014.05.011
Kjaergaard, K D, Peters, C D, Jespersen, B, Tietze, I N, Madsen, J K, Pedersen, B B, Novosel, M K, Laursen, K S, Bibby, B M, Strandhave, C & Jensen, J D 2014, ' Angiotensin Blockade and Progressive Loss of Kidney Function in Hemodialysis Patients : A Randomized Controlled Trial ', American Journal of Kidney Diseases, vol. 64, no. 6, pp. 892-901 . https://doi.org/10.1053/j.ajkd.2014.05.011
BACKGROUND: Glomerular filtration rate (GFR) declines during long-term dialysis treatment. In peritoneal dialysis, blockade of the renin-angiotensin-aldosterone system reduces GFR decline. Observational studies suggest that similar treatment may pres